| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RYTM | Common Stock | Options Exercise | $140K | +20.6K | +300.96% | $6.80 | 27.5K | Nov 11, 2024 | Direct | |
| transaction | RYTM | Common Stock | Options Exercise | $698K | +28.7K | +104.52% | $24.29 | 56.2K | Nov 11, 2024 | Direct | |
| transaction | RYTM | Common Stock | Options Exercise | $357K | +11.6K | +20.72% | $30.66 | 67.8K | Nov 11, 2024 | Direct | |
| transaction | RYTM | Common Stock | Sale | -$2.5M | -38.1K | -56.1% | $65.68 | 29.8K | Nov 11, 2024 | Direct | F1, F2 |
| transaction | RYTM | Common Stock | Sale | -$1.17M | -17.5K | -58.89% | $66.95 | 12.2K | Nov 11, 2024 | Direct | F1, F3 |
| transaction | RYTM | Common Stock | Sale | -$748K | -11.1K | -90.43% | $67.56 | 1.17K | Nov 11, 2024 | Direct | F1, F4 |
| transaction | RYTM | Common Stock | Sale | -$13.7K | -200 | -17.06% | $68.43 | 972 | Nov 11, 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RYTM | Stock Option (Right to Buy) | Options Exercise | $0 | -20.6K | -44.43% | $0.00 | 25.8K | Nov 11, 2024 | Common Stock | 20.6K | $6.80 | Direct | F5 |
| transaction | RYTM | Stock Option (Right to Buy) | Options Exercise | $0 | -28.7K | -28.72% | $0.00 | 71.3K | Nov 11, 2024 | Common Stock | 28.7K | $24.29 | Direct | F6 |
| transaction | RYTM | Stock Option (Right to Buy) | Options Exercise | $0 | -11.6K | -23.88% | $0.00 | 37.1K | Nov 11, 2024 | Common Stock | 11.6K | $30.66 | Direct | F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024. |
| F2 | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $65.18 to $66.1799 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $66.33 to $67.3299 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $67.33 to $68.3299 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. |
| F6 | The stock options were granted on November 9, 2020. The options are fully vested. |
| F7 | The stock options were granted on February 11, 2021. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. |
Exhibit 24